e-therapeutics (ETX) Insider Trading & Ownership GBX 9 -0.65 (-6.74%) (As of 05/8/2024) Add Compare Share Share Insider Trades Stock AnalysisHeadlinesInsider Trades e-therapeutics (LON:ETX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage59.44%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£7,306.00Number OfInsiders Selling(Last 12 Months)0 Get ETX Insider Trade Alerts Want to know when executives and insiders are buying or selling e-therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ETX Insider Buying and Selling by Quarter Ad Jack Carter Trading"X-Ray Vision" could find thousands of hidden market opportunitiesLet me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.Just tap here to join the presentation. e-therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/9/2024Trevor Mervyn JonesInsiderBuy91,325GBX 8£7,306 (Data available from 1/1/2013 forward) ETX Insider Trading Activity - Frequently Asked Questions Who is on e-therapeutics's Insider Roster? The list of insiders at e-therapeutics includes Trevor Mervyn Jones. Learn more on insiders at ETX. What percentage of e-therapeutics stock is owned by insiders? 59.44% of e-therapeutics stock is owned by insiders. Learn more on ETX's insider holdings. Which e-therapeutics insiders have been buying company stock? The following insider purchased ETX shares in the last 24 months: Trevor Mervyn Jones (£22,508.10). How much insider buying is happening at e-therapeutics? Insiders have purchased a total of 170,505 ETX shares in the last 24 months for a total of £22,508.10 bought. e-therapeutics Key ExecutivesMr. Ahmad Ali Mortazavi (Age 53)CEO & Director Compensation: $270kMr. Timothy BrethertonCFO, Director of Finance & Operations and Company SecretaryDr. Laura Roca-Alonso Ph.D.Chief Operating & Business OfficerMr. Alan Whitmore B.Sc.Ph.D., Chief Scientific OfficerMr. Ankit SharmaHead of Software EngineeringMr. Graham CraggsHead of Therapeutic Discovery More Insider Trading Tools from MarketBeat Related Companies Arix Bioscience Insider Transactions Bioventix Insider Transactions 4basebio Insider Transactions Tissue Regenix Group Insider Transactions Poolbeg Pharma Insider Transactions Sareum Insider Transactions Oncimmune Insider Transactions BiVictriX Therapeutics Insider Transactions Fusion Antibodies Insider Transactions Roquefort Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:ETX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding e-therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share e-therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
